特朗普提名的FDA局长人选出席参院确认听证会 堕胎药与疫苗政策成焦点Trump's FDA Nominee Overton Faces Senate Hearing on Abortion Pill and Vaccines

在确认听证会上，参议院委员会重点审视了奥弗顿对堕胎药米非司酮的监管立场。卡西迪要求现届政府废除拜登执政时期允许通过远程医疗开具米非司酮并经邮寄送达的规定。在8月发布的委员会报告中，卡西迪指责米非司酮生产商未能履行确保符合FDA安全法规的法定责任，特别是在通过第三方供应商在线销售药品的环节。卡西迪曾在1月要求卫生部长小罗伯特·F·肯尼迪及前局长马卡里完成相关安全审查，FDA随后于6月启动了针对米非司酮的新安全研究。

During the confirmation hearing, the Senate committee focused on Overton's regulatory position regarding the abortion pill mifepristone. Cassidy has pushed the administration to reverse a Biden-era rule that allows mifepristone to be prescribed via telemedicine and delivered through the mail. In a committee report released last month, Cassidy accused the makers of mifepristone of failing to meet their legal responsibilities to ensure compliance with FDA safety regulations, specifically when pills are sold online through third-party providers. Cassidy previously called on Health Secretary Robert F. Kennedy Jr. and former commissioner Makary in January to complete a promised safety review, and the FDA initiated a new safety study on the medication in June.

作为一名预防医学医生，奥弗顿现任白宫国内政策官员，此前曾担任保守派智库“美国优先政策研究所”的首席政策官。奥弗顿曾赞扬联邦最高法院推翻“罗诉韦德案”判决的裁决，主张对药物流产施加严格限制，并称该药物对女性构成危险。纽约大学格罗斯曼医学院医学伦理部门负责人阿特·卡普兰指出，奥弗顿在堕胎议题上的立场与卡西迪的主张趋于一致。研究数据显示，米非司酮即便在家中使用也是安全且有效的。

A preventive medicine physician currently serving as a White House domestic policy official, Overton previously worked as chief policy officer at the conservative America First Policy Institute. In that role, she praised the Supreme Court's decision overturning Roe v. Wade and called for strict restrictions on medication abortion, asserting that the drug is dangerous to women. Art Caplan, head of the medical ethics division at NYU Grossman School of Medicine, noted that Overton's views on abortion appear aligned with Cassidy's objectives, even as clinical studies demonstrate that mifepristone remains safe and effective when taken at home.

在疫苗政策领域，奥弗顿被视为卫生部长肯尼迪所倡导的“让美国再次健康”行动的支持者。作为白宫国内政策官员，奥弗顿曾参与减少儿童常规推荐疫苗数量的相关工作。8月特朗普宣布签署旨在减少儿童常规推荐疫苗的行政令时，奥弗顿曾陪同出席，特朗普在数日后正式宣布提名其执掌FDA。加利福尼亚大学旧金山分校法学教授兼疫苗政策专家多丽特·赖斯指出，奥弗顿已明确表明自己支持肯尼迪的疫苗政策主张，参议员在听证会上势必对她的具体疫苗立场展开严格质询。

Regarding federal immunization policy, Overton is known as a proponent of Health Secretary Robert F. Kennedy Jr.'s "Make America Healthy Again" agenda. During her tenure as a White House domestic policy official, Overton worked on efforts aimed at reducing the number of vaccines routinely recommended for children. In August, she appeared alongside President Trump when he unveiled an executive order reducing childhood vaccine recommendations, and Trump announced her nomination to lead the FDA days later. Dorit Reiss, a professor of law and vaccine policy expert at the University of California Law San Francisco, noted that Overton has made clear her support for Kennedy's vaccine agenda, prompting senators to closely examine her perspectives.

卡西迪在听证会前对多名政府提名人选的疫苗政策立场表达关切，并要求奥弗顿公开阐明立场。特朗普在8月签署相关行政令期间曾公开宣称麻疹疫苗具有致命性，卡西迪随后在接受哥伦比亚广播公司采访时明确要求奥弗顿在委员会面前承认该言论荒谬。奥弗顿如何回应特朗普关于麻疹疫苗的表态以及如何界定自身与肯尼迪疫苗议程的关系，成为参议员在听证会中审视其监管科学决策独立性的核心关切。

Cassidy, who has questioned several administration nominees regarding vaccine oversight, demanded that Overton address Trump's public statements on immunizations. During the August executive order signing, Trump asserted that the measles vaccine is lethal, leading Cassidy to state on CBS News that Overton must acknowledge that assertion as absurd before the committee. How Overton addresses Trump's characterization of the measles vaccine and clarifies her regulatory approach alongside Kennedy's broader agenda represent central focal points as lawmakers evaluate her readiness to lead the public health agency.

针对奥弗顿的任命，外界对其能否有效管理庞大复杂的监管机构提出了资质疑问。多丽特·赖斯指出，奥弗顿缺乏临床试验、机构管理或FDA监管产品的专业背景，更像是因政治观点而非专业资质获得提名的典型人选。白宫发言人库什·德赛对此回应称，奥弗顿拥有医学博士及哲学博士学位，曾在特朗普第一任期内协助推进“曲速行动”，将确保FDA的政策制定完全遵循最高标准的科学依据。

Overton's nomination has drawn scrutiny from experts questioning her readiness to direct a complex regulatory body. Vaccine policy expert Dorit Reiss observed that Overton lacks demonstrated expertise in clinical trials, agency administration, or the specific products regulated by the FDA, describing her as an appointee selected primarily for political perspectives rather than technical qualifications. In defense of the nominee, White House spokesman Kush Desai stated that Overton is an MD/PhD who helped deliver on Operation Warp Speed during Trump's first term and will ensure policymaking is guided solely by gold-standard science at the FDA.

前FDA代理局长斯蒂芬·奥斯特洛夫指出，食品安全是奥弗顿若获确认将面临的另一项严峻考验。前局长马卡里因政府批准多款成人水果味电子烟等分歧于5月辞职后，FDA领导层持续空缺。该机构在夏季应对了多起食源性疾病暴发与召回事件，包括与结球生菜相关的环孢子虫暴发，导致多个州超过1.2万人患病。该事件引发了对FDA食品溯源效率以及在过去一年数千名员工离职或被裁后是否拥有充足应对人手的广泛质疑。

Former acting FDA commissioner Dr. Stephen Ostroff noted that food safety represents another major operational challenge awaiting the nominee. The agency has lacked a permanent leader since Dr. Marty Makary resigned in May, partly over the administration's authorization of several fruit-flavored vapes for adults. Throughout the summer, the FDA handled a series of foodborne illness outbreaks and product recalls, including a massive cyclospora outbreak linked to iceberg lettuce that sickened over 12,000 people across multiple states. The outbreak highlighted questions regarding how rapidly the FDA can trace contaminated foods to their source and whether the agency maintains sufficient personnel after thousands of employees left or were laid off over the past year.